Afatinib dimaleate is used in the treatment of non-small cell lung cancer. It is indicated for adult patients who have specific EGFR mutations.
How Afatinib dimaleate works Afatinib dimaleate is an anti-cancer medication. It functions by binding to and inhibiting the enzyme receptors (EGFR, HER2, and HER4) that are responsible for the growth of cancer cells, leading to the downregulation of signaling pathways. This mechanism helps to stop or slow the spread of cancer.
Common side effects of Afatinib dimaleate include nausea, vomiting, diarrhea, itching, rash, stomatitis (inflammation of the mouth), loss of appetite, dry skin, decreased appetite, and nail disorders.